Ignite Creation Date:
2024-05-05 @ 9:56 PM
Last Modification Date:
2024-10-26 @ 10:11 AM
Study NCT ID:
NCT00992186
Status:
COMPLETED
Last Update Posted:
2013-06-24
First Post:
2009-09-29
Brief Title:
A Study of the Safety and Efficacy of Single-agent Carlumab an Anti-Chemokine Ligand 2 CCL2 in Participants With Metastatic Castrate-Resistant Prostate Cancer
Sponsor:
Centocor Research Development Inc
Organization:
Centocor Research Development Inc
Organization Data
Organization:
Centocor Research Development Inc
Class:
INDUSTRY
Study ID:
CR015907
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Centocor Research Development Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None